Cookies on our website

We use cookies on our website. To learn more about cookies, how we use them on our site and how to change your cookie settings please view our cookie policy.

Read more Close
Skip Ribbon Commands
Skip to main content
You searched for:
Search

Search

1-10 of 17 results
Results per page: 
Sort by: 
Outstanding performance by A&O in Global M&A league tables 2019 Outstanding performance by A&O in Global M&A league tables 2019
04 October 2019
http://www.allenovery.com/news/en-gb/articl … e-by-a-and-o-in-global-ma-league-tables.aspx
​A&O has climbed the tables in the recently published Adviser Rankings league tables, ranking second by number of FTSE 100 clients. The latest tables list A&O as advising 26 FTSE 100 clients. A&O has climbed the tables in the recently published Adviser Rankings league tables, ranking second by
06 September 2019
http://www.allenovery.com/news/en-gb/articl … strong-performance-in-ftse-100-rankings.aspx
Allen & Overy has advised Cathay Capital Private Equity on the acquisition of a minority stake in medifa healthcare group GmbH, a globally active medical technology company. Allen & Overy has advised Cathay Capital Private Equity on the acquisition of a minority stake in medifa healthcare group
31 July 2019
http://www.allenovery.com/news/en-gb/articl … eiligung-an-der-medifa-healthcare-group.aspx
Allen & Overy Casablanca advises KMR in the acquisition of Laureate SOMED Education Holding CASABLANCA - Allen & Overy (A&O) advised KMR Holding Pédagogique (KMR) in the acquisition through its wholly-owned subsidary Université Privée de Marrakech Pédagogique (UPM) of 100% of the share capital of
24 January 2018
http://www.allenovery.com/news/en-gb/articl … ion-of-Laureate-SOMED-Education-Holding.aspx
​A&O, once again demonstrating our track record of acting on, and successfully completing, complex high-value transactions in a wide range of sectors and markets. A&O, once again demonstrating our track record of acting on, and successfully completing, complex high-value transactions in a wide
10 July 2018
http://www.allenovery.com/news/en-gb/articl … es-show-strength-of-AO’s-global-MA-team.aspx
Allen & Overy has advised science-based pharmaceutical company Grünenthal on its acquisition of AstraZeneca’s European rights to prescription Nexium and the global (excluding the US and Japan) rights . Allen & Overy has advised science-based pharmaceutical company Grünenthal on its acquisition of
30 October 2018
http://www.allenovery.com/news/en-gb/articl … -with-AstraZeneca-for-Nexium-and-Vimovo.aspx
A&O has marked the end of Q4 2018 with an extremely strong performance in the M&A league tables. A&O has marked the end of Q4 2018 with an extremely strong performance in the M&A league tables.
09 January 2019
http://www.allenovery.com/news/en-gb/articl … rmance-by-ao-in-global-ma-league-tables.aspx
The recovery in global M&A markets is developing a broader base according to Allen & Overy’s latest M&A Index. The recovery in global M&A markets is developing a broader base according to Allen & Overy’s latest M&A Index.
10 July 2014
http://www.allenovery.com/news/en-gb/articl … es-led-by-TMT-and-Life-Sciences-sectors.aspx
Allen & Overy has advised the founders and shareholders of Walmark, Czech manufacturer of dietary supplements, OTC pharmaceuticals and other related products with subsidiaries in 10 other European countries, on the 50% capital entry by Mid Europa Partners, one of the leading private equity funds in
17 August 2012
http://www.allenovery.com/news/en-gb/articles/Pages/Walmark-Mid Europa.aspx
Allen & Overy LLP has advised Cleanpart Group GmbH (Cleanpart), a portfolio company of Deutsche Beteiligungs AG (DBAG), on the sale if its healthcare business to VAMED, a service provider for hospitals that is majority-owned by Fresenius SE & Co. KGaA.
07 November 2017
http://www.allenovery.com/news/en-gb/articl … eim-Verkauf-ihres-Healthcare-Geschäfts-.aspx


  • Add comment (optional)